Evidence map›Paper›PMID 39080020›Full record

ArticleSignal transduction and targeted therapy2024

Adhesion G protein-coupled receptor latrophilin 1 (ADGRL1): a novel regulator of glucose and energy homeostasis.

Kavaljit H Chhabra

Abstract read
In one paragraph

Article in Signal transduction and targeted therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Glucose sensing and homeostasis by adipocyte GPCR.Frontiers in endocrinology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kavaljit H ChhabraDepartment of Pharmacology and Nutritional Sciences, Barnstable Brown Diabetes and Obesity Research Center, University of Kentucky, Lexington, KY, USA. Kavaljit_chhabra@UKY.Edu.ORCID 0000-0001-6378-3645

Funding

Role of Hypothalamic MC4R in Glucose Homeostasis via a Novel Neuroendocrine Circuit involving the Kidneys and Adrenal GlandsR01DK124619 · NIDDK · UNIVERSITY OF ROCHESTER · PI CHHABRA, KAVALJIT H · 2021 to 2025
$2.0M
Role of Hypothalamic Adgrl1 in Counteracting HypoglycemiaR01DK140148 · NIDDK · UNIVERSITY OF KENTUCKY · PI Kavaljit H Chhabra · 2025 to 2026
$1.0M
Role of Hypothalamic Adgrl1 in Counteracting HypoglycemiaR56DK140148 · NIDDK · UNIVERSITY OF KENTUCKY · PI CHHABRA, KAVALJIT H · 2024 to 2024
$294k
NIDDK NIH HHS R01 DK124619NIDDK NIH HHS R01 DK140148NIDDK NIH HHS R56 DK140148U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) DK124619
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GlucoseHomeostasisReceptors, G-Protein-CoupledAnimalsEnergy MetabolismHumansReceptors, PeptideGlucoseReceptors, G-Protein-CoupledReceptors, Peptide

Identifiers

PMID39080020
PMCPMC11289090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.